HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
1326studies shown
Showing 361-372 of 1,326
Other study type icon
Not Yet RecruitingNCT07455981

Work Organization and Gambling Addiction

Official study title

Assessment of the Interaction Between Atypical Working Hours and/or Periods of Inactivity on Risky Gambling Practices Among Adults Working Under These Conditions.

This study isn't recruiting yet.

In France
AddictionObservational studyAges 18+
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Behavioral study icon
CompletedNCT01964456

"Self-consciousness and the Inter-subjective Body"

Official study title

"Narcisse & Echo : Self-consciousness and the Inter-subjective Body"

This study has finished and is no longer accepting participants.

In France
Eating disordersBehavioural studyAges 18–35
Countries
France
Sponsor
Centre Hospitalier St Anne
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

What is this study about?

This study evaluated the safety and effectiveness of Esketamine for people with depression.

This study has finished and is no longer accepting participants.

In France
Depression, SuicidalityMedication studyAges 18–64
Countries
France, United States, Canada, + 9 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedEUCTR 2007-005959-42

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolarity type I Pat...

Official study title

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Pat...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
BipolarityHistorical research record
Countries
France, Austria, Czechia, + 6 others
Sponsor
Bristol Myers Squibb International Corporation
Drug study icon
CompletedEUCTR 2008-002247-16

A 24-month, Prospective, Randomized, Active-Controlled, Open-Label, Rater Blinded, Multicenter, International Study of the Prevention of Relapse Comparing Long-Acting Injectable Paliperidone Palmit...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, United Kingdom, Belgium, + 10 others
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedNCT00645099

A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in people with Schizophrenia

Official study title

A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, Argentina, Egypt, + 11 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2013-001695-38

A 6-WEEK RANDOMIZED, PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENT SUBJECTS WITH SCHIZOPHRENIA

This study has finished and is no longer accepting participants.

Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.

In France
SchizophreniaHistorical research recordAges 13–17
Countries
France, United States, United Kingdom, + 13 others
Sponsor
SUNOVION PHARMACEUTICALS INC.
Device study icon
CompletedNCT02505126

A study on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM)

Official study title

A Randomized Double-blind Clinical Trial on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder

This study has finished and is no longer accepting participants.

In France
AddictionDevice studyAges 18+
Countries
France
Sponsor
Centre Hospitalier Universitaire Dijon
Drug study icon
TerminatedNCT01328093

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Official study title

A Phase 3, Multicenter, Double-Blind Comparison of LY2140023 and Aripiprazole in Patients With DSM-IV-TR Schizophrenia Followed by Open-Label Treatment With LY2140023

This study ended early.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, United States, Belgium, + 6 others
Sponsor
Denovo Biopharma LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.